- Home
- ORGO vs FRA Comparison
ORGO vs FRA Comparison
Compare ORGO & FRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- FRA
- Stock Information
- Founded
- ORGO 1985
- FRA 2003
- Country
- ORGO United States
- FRA United States
- Employees
- ORGO N/A
- FRA N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- FRA Investment Bankers/Brokers/Service
- Sector
- ORGO Health Care
- FRA Finance
- Exchange
- ORGO Nasdaq
- FRA Nasdaq
- Market Cap
- ORGO 465.6M
- FRA 449.1M
- IPO Year
- ORGO N/A
- FRA N/A
- Fundamental
- Price
- ORGO $4.32
- FRA $13.23
- Analyst Decision
- ORGO Hold
- FRA
- Analyst Count
- ORGO 1
- FRA 0
- Target Price
- ORGO $6.00
- FRA N/A
- AVG Volume (30 Days)
- ORGO 918.2K
- FRA 165.4K
- Earning Date
- ORGO 08-07-2025
- FRA 01-01-0001
- Dividend Yield
- ORGO N/A
- FRA 11.06%
- EPS Growth
- ORGO N/A
- FRA N/A
- EPS
- ORGO N/A
- FRA N/A
- Revenue
- ORGO $458,760,000.00
- FRA N/A
- Revenue This Year
- ORGO $1.10
- FRA N/A
- Revenue Next Year
- ORGO $9.93
- FRA N/A
- P/E Ratio
- ORGO N/A
- FRA N/A
- Revenue Growth
- ORGO 5.35
- FRA N/A
- 52 Week Low
- ORGO $2.28
- FRA $11.33
- 52 Week High
- ORGO $6.71
- FRA $13.10
- Technical
- Relative Strength Index (RSI)
- ORGO 68.34
- FRA 68.55
- Support Level
- ORGO $3.59
- FRA $13.18
- Resistance Level
- ORGO $4.70
- FRA $13.33
- Average True Range (ATR)
- ORGO 0.23
- FRA 0.10
- MACD
- ORGO 0.12
- FRA 0.01
- Stochastic Oscillator
- ORGO 81.15
- FRA 83.67
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About FRA Blackrock Floating Rate Income Strategies Fund Inc
Blackrock Floating Rate Inc Stra Fd Inc is a United States-based diversified closed-ended management investment company. The Fund's investment objective is to provide shareholders with high current income and preservation of capital with investment in a diversified, leveraged portfolio consisting of floating-rate debt securities and instruments.